Outbreak of Pseudomonas aeruginosa producing VIM carbapenemase in an intensive care unit and its termination by implementation of waterless patient care.
Adult
Aged
Bacterial Proteins
/ pharmacology
Cross Infection
/ epidemiology
Disease Outbreaks
/ statistics & numerical data
Epidemiology
Equipment Contamination
Female
Humans
Iatrogenic Disease
/ epidemiology
Intensive Care Units
/ organization & administration
Male
Middle Aged
Pseudomonas Infections
/ drug therapy
Pseudomonas aeruginosa
/ drug effects
Switzerland
/ epidemiology
beta-Lactamases
/ pharmacology
Aquatic reservoir
Carbapememase
Outbreak
Pseudomonas aeruginosa
Sink
VIM
Waterless
cgMLST
Journal
Critical care (London, England)
ISSN: 1466-609X
Titre abrégé: Crit Care
Pays: England
ID NLM: 9801902
Informations de publication
Date de publication:
19 08 2021
19 08 2021
Historique:
received:
14
06
2021
accepted:
09
08
2021
entrez:
20
8
2021
pubmed:
21
8
2021
medline:
21
10
2021
Statut:
epublish
Résumé
Long-term outbreaks of multidrug-resistant Gram-negative bacilli related to hospital-building water systems have been described. However, successful mitigation strategies have rarely been reported. In particular, environmental disinfection or replacement of contaminated equipment usually failed to eradicate environmental sources of Pseudomonas aeruginosa. We report the investigation and termination of an outbreak of P. aeruginosa producing VIM carbapenemase (PA-VIM) in the adult intensive care unit (ICU) of a Swiss tertiary care hospital with active case finding, environmental sampling and whole genome sequencing (WGS) of patient and environmental strains. We also describe the implemented control strategies and their effectiveness on eradication of the environmental reservoir. Between April 2018 and September 2020, 21 patients became either infected or colonized with a PA-VIM strain. For 16 of them, an acquisition in the ICU was suspected. Among 131 environmental samples collected in the ICU, 13 grew PA-VIM in sink traps and drains. WGS confirmed the epidemiological link between clinical and environmental strains and the monoclonal pattern of the outbreak. After removing sinks from patient rooms and implementation of waterless patient care, no new acquisition was detected in the ICU within 8 months after the intervention. Implementation of waterless patient care with removal of the sinks in patient rooms was successful for termination of a PA-VIM ICU outbreak linked to multiple environmental water sources. WGS provides highly discriminatory accuracy to investigate environment-related outbreaks.
Sections du résumé
BACKGROUND
Long-term outbreaks of multidrug-resistant Gram-negative bacilli related to hospital-building water systems have been described. However, successful mitigation strategies have rarely been reported. In particular, environmental disinfection or replacement of contaminated equipment usually failed to eradicate environmental sources of Pseudomonas aeruginosa.
METHODS
We report the investigation and termination of an outbreak of P. aeruginosa producing VIM carbapenemase (PA-VIM) in the adult intensive care unit (ICU) of a Swiss tertiary care hospital with active case finding, environmental sampling and whole genome sequencing (WGS) of patient and environmental strains. We also describe the implemented control strategies and their effectiveness on eradication of the environmental reservoir.
RESULTS
Between April 2018 and September 2020, 21 patients became either infected or colonized with a PA-VIM strain. For 16 of them, an acquisition in the ICU was suspected. Among 131 environmental samples collected in the ICU, 13 grew PA-VIM in sink traps and drains. WGS confirmed the epidemiological link between clinical and environmental strains and the monoclonal pattern of the outbreak. After removing sinks from patient rooms and implementation of waterless patient care, no new acquisition was detected in the ICU within 8 months after the intervention.
DISCUSSION
Implementation of waterless patient care with removal of the sinks in patient rooms was successful for termination of a PA-VIM ICU outbreak linked to multiple environmental water sources. WGS provides highly discriminatory accuracy to investigate environment-related outbreaks.
Identifiants
pubmed: 34412676
doi: 10.1186/s13054-021-03726-y
pii: 10.1186/s13054-021-03726-y
pmc: PMC8376114
doi:
Substances chimiques
Bacterial Proteins
0
beta-Lactamases
EC 3.5.2.6
carbapenemase
EC 3.5.2.6
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
301Informations de copyright
© 2021. The Author(s).
Références
Antimicrob Agents Chemother. 2014 May;58(5):2626-37
pubmed: 24550343
Intensive Care Med. 2018 Nov;44(11):1777-1786
pubmed: 30343312
Clin Infect Dis. 2017 May 15;64(10):1435-1444
pubmed: 28200000
Infect Control Hosp Epidemiol. 2009 Jan;30(1):25-33
pubmed: 19046054
Clin Microbiol Rev. 2007 Jul;20(3):440-58, table of contents
pubmed: 17630334
Front Microbiol. 2020 Jul 22;11:1729
pubmed: 32793169
Curr Opin Infect Dis. 2013 Aug;26(4):345-51
pubmed: 23806897
Infect Control Hosp Epidemiol. 2018 Dec;39(12):1463-1466
pubmed: 30526717
Diagn Microbiol Infect Dis. 2015 Aug;82(4):274-7
pubmed: 25952482
Swiss Med Wkly. 2009 Dec 26;139(51-52):747-51
pubmed: 19924582
J Clin Microbiol. 2015 Aug;53(8):2622-31
pubmed: 26041902
J Antimicrob Chemother. 2003 Jun;51(6):1409-14
pubmed: 12716773
Infect Control Hosp Epidemiol. 2004 Dec;25(12):1083-9
pubmed: 15636297
Clin Infect Dis. 2004 Aug 15;39(4):511-6
pubmed: 15356814
Infect Control Hosp Epidemiol. 2018 Dec;39(12):1467-1469
pubmed: 30526714
Crit Care Explor. 2020 Jul 29;2(8):e0173
pubmed: 32766566
Clin Microbiol Infect. 2019 Jul;25(7):830-838
pubmed: 30616014
Pediatr Infect Dis J. 2010 Mar;29(3):233-7
pubmed: 19940801
Antimicrob Agents Chemother. 2013 Jul;57(7):3224-9
pubmed: 23629703
Clin Infect Dis. 2019 Feb 15;68(5):873-884
pubmed: 30475989
Expert Rev Anti Infect Ther. 2019 Aug;17(8):557-569
pubmed: 31313610
Infect Control Hosp Epidemiol. 2019 Jun;40(6):621-626
pubmed: 30942147
N Engl J Med. 2005 Jan 27;352(4):380-91
pubmed: 15673804
J Hosp Infect. 2016 Sep;94(1):2-7
pubmed: 27451039
Euro Surveill. 2013 Oct 17;18(42):
pubmed: 24176582
Nature. 2000 Aug 31;406(6799):959-64
pubmed: 10984043
Lancet Infect Dis. 2018 Mar;18(3):318-327
pubmed: 29276051
Am J Infect Control. 2005 Jun;33(5 Suppl 1):S26-40
pubmed: 15940114
Front Public Health. 2020 Jan 28;8:3
pubmed: 32047733
J Clin Microbiol. 2017 Sep;55(9):2858-2864
pubmed: 28701421
Clin Infect Dis. 2016 Jun 1;62(11):1423-35
pubmed: 26936670
Antimicrob Resist Infect Control. 2020 Feb 11;9(1):29
pubmed: 32046775
Infect Control Hosp Epidemiol. 2018 Dec;39(12):1497-1498
pubmed: 30526713